CACT expression was negatively correlated with tumor malignancy, with CACT expression downregulated in poorly differentiated G3 carcinomas compared to NMGs, well-differentiated (G1) and moderately differentiated (G2) carcinomas. The gene discussed is SLC25A20; the disease is carcinoma.